Clinical Trials List
2014-06-01 - 2018-08-09
Phase II
Terminated5
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
COVANCE TAIWAN SERVICES LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 張英勛 Division of Urology
- Feng-Yuan Liu Division of Nuclear Medicine
- Rita cheng Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王世楨 Division of Nuclear Medicine
- 沈書慧 Division of Radiology
- Yi-Hsiu Huang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林仁泰 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- 劉詩彬 Division of Urology
- 戴槐青 Division of Urology
- MEI-FANG CHENG Division of Nuclear Medicine
- Yeong-Shiau Pu Division of Urology
- SHUO-MENG WANG Division of Urology
- RUOH-FANG YEN Division of Nuclear Medicine
- - - Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Cheng-Kuang Yang Division of Urology
- 熊小澐 Division of Radiology
- 洪啟峰 Division of Urology
- Shian-Shiang Wang Division of Urology
- Jian-Ri Li Division of Urology
- Chuan-Shu Chen Division of Urology
- 林萬鈺 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
360 participants
